• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖酵解相关基因表达谱可作为预测人肝细胞癌预后的新风险预测因子。

Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma.

机构信息

Department of Laboratory Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, People's Republic of China.

Department of Biochemistry and Molecular Biology, Bengbu Medical College, Anhui, 233030, People's Republic of China.

出版信息

Sci Rep. 2021 Sep 23;11(1):18875. doi: 10.1038/s41598-021-98381-2.

DOI:10.1038/s41598-021-98381-2
PMID:34556750
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8460833/
Abstract

Metabolic pattern reconstruction is an important factor in tumor progression. Metabolism of tumor cells is characterized by abnormal increase in anaerobic glycolysis, regardless of high oxygen concentration, resulting in a significant accumulation of energy from glucose sources. These changes promotes rapid cell proliferation and tumor growth, which is further referenced a process known as the Warburg effect. The current study reconstructed the metabolic pattern in progression of cancer to identify genetic changes specific in cancer cells. A total of 12 common types of solid tumors were included in the current study. Gene set enrichment analysis (GSEA) was performed to analyze 9 glycolysis-related gene sets, which are implicated in the glycolysis process. Univariate and multivariate analyses were used to identify independent prognostic variables for construction of a nomogram based on clinicopathological characteristics and a glycolysis-related gene prognostic index (GRGPI). The prognostic model based on glycolysis genes showed high area under the curve (AUC) in LIHC (Liver hepatocellular carcinoma). The findings of the current study showed that 8 genes (AURKA, CDK1, CENPA, DEPDC1, HMMR, KIF20A, PFKFB4, STMN1) were correlated with overall survival (OS) and recurrence-free survival (RFS). Further analysis showed that the prediction model accurately distinguished between high- and low-risk cancer patients among patients in different clusters in LIHC. A nomogram with a well-fitted calibration curve based on gene expression profiles and clinical characteristics showed good discrimination based on internal and external cohorts. These findings indicate that changes in expression level of metabolic genes implicated in glycolysis can contribute to reconstruction of tumor-related microenvironment.

摘要

代谢模式重建是肿瘤进展的一个重要因素。肿瘤细胞的代谢特点是无氧糖酵解异常增加,无论氧浓度如何,都导致葡萄糖来源的能量大量积累。这些变化促进了细胞的快速增殖和肿瘤的生长,这进一步被称为沃伯格效应。本研究重建了癌症进展中的代谢模式,以确定癌细胞中特有的遗传变化。本研究共纳入 12 种常见的实体肿瘤。采用基因集富集分析(GSEA)分析了 9 个与糖酵解相关的基因集,这些基因集与糖酵解过程有关。采用单变量和多变量分析,根据临床病理特征和糖酵解相关基因预后指数(GRGPI)构建列线图,确定独立的预后变量。基于糖酵解基因的预后模型在 LIHC(肝肝细胞癌)中表现出较高的曲线下面积(AUC)。本研究的结果表明,8 个基因(AURKA、CDK1、CENPA、DEPDC1、HMMR、KIF20A、PFKFB4、STMN1)与总生存期(OS)和无复发生存期(RFS)相关。进一步分析表明,该预测模型能够准确区分 LIHC 不同聚类患者中高风险和低风险癌症患者。基于基因表达谱和临床特征的列线图具有良好的校准曲线拟合度,在内部和外部队列中均具有良好的区分度。这些发现表明,与糖酵解相关的代谢基因表达水平的变化可能有助于重建肿瘤相关的微环境。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/b096af689df8/41598_2021_98381_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/29bd3ae03bb1/41598_2021_98381_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/d47fd1333a10/41598_2021_98381_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/18ca4cfe1705/41598_2021_98381_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/09f500a96195/41598_2021_98381_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/21eb5b31c1c6/41598_2021_98381_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/0cd2fa9f6fc0/41598_2021_98381_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/af75784b38d9/41598_2021_98381_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/a067b9112ef1/41598_2021_98381_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/28b08bc7e986/41598_2021_98381_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/66a7a2007511/41598_2021_98381_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/2c853b40c24b/41598_2021_98381_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/b096af689df8/41598_2021_98381_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/29bd3ae03bb1/41598_2021_98381_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/d47fd1333a10/41598_2021_98381_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/18ca4cfe1705/41598_2021_98381_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/09f500a96195/41598_2021_98381_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/21eb5b31c1c6/41598_2021_98381_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/0cd2fa9f6fc0/41598_2021_98381_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/af75784b38d9/41598_2021_98381_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/a067b9112ef1/41598_2021_98381_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/28b08bc7e986/41598_2021_98381_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/66a7a2007511/41598_2021_98381_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/2c853b40c24b/41598_2021_98381_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e28/8460833/b096af689df8/41598_2021_98381_Fig12_HTML.jpg

相似文献

1
Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma.糖酵解相关基因表达谱可作为预测人肝细胞癌预后的新风险预测因子。
Sci Rep. 2021 Sep 23;11(1):18875. doi: 10.1038/s41598-021-98381-2.
2
Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.基于氧化还原免疫的肝细胞癌预后标志物的鉴定和验证。
Int J Med Sci. 2021 Mar 10;18(9):2030-2041. doi: 10.7150/ijms.56289. eCollection 2021.
3
Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.基于肝癌微环境构建风险评分预后模型。
World J Gastroenterol. 2020 Jan 14;26(2):134-153. doi: 10.3748/wjg.v26.i2.134.
4
Identification and validation of a potent multi-mRNA signature for the prediction of early relapse in hepatocellular carcinoma.鉴定和验证一种有效的多信使 RNA 标志物,用于预测肝细胞癌的早期复发。
Carcinogenesis. 2019 Jul 20;40(7):840-852. doi: 10.1093/carcin/bgz018.
5
Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma.鉴定与糖酵解相关的基因特征,用于预测肝细胞癌患者的预后。
BMC Cancer. 2022 Feb 5;22(1):142. doi: 10.1186/s12885-022-09209-9.
6
Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.基于上皮-间质转化相关基因 BIRC5 鉴定肝细胞癌的预后标志物。
BMC Cancer. 2021 Jun 10;21(1):687. doi: 10.1186/s12885-021-08390-7.
7
Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.长链非编码 RNA 标志物预测肝细胞癌无复发生存率。
World J Gastroenterol. 2019 Jan 14;25(2):220-232. doi: 10.3748/wjg.v25.i2.220.
8
Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.基于 TCGA 数据的肝癌肿瘤突变负荷和免疫浸润的预后分析。
Aging (Albany NY). 2021 Apr 4;13(8):11257-11280. doi: 10.18632/aging.202811.
9
Diagnostic significance and carcinogenic mechanism of pan-cancer gene POU5F1 in liver hepatocellular carcinoma.POU5F1 基因在肝癌中的多癌种诊断意义及其致癌机制。
Cancer Med. 2020 Dec;9(23):8782-8800. doi: 10.1002/cam4.3486. Epub 2020 Sep 26.
10
Glycolysis gene expression profilings screen for prognostic risk signature of hepatocellular carcinoma.糖酵解基因表达谱筛选肝细胞癌的预后风险特征。
Aging (Albany NY). 2019 Dec 2;11(23):10861-10882. doi: 10.18632/aging.102489.

引用本文的文献

1
DEPDC1 facilitated malignant phenotypes and disease progression of liposarcoma by modulating KIF20A.DEPDC1通过调节KIF20A促进脂肪肉瘤的恶性表型和疾病进展。
Front Endocrinol (Lausanne). 2025 Jun 17;16:1591390. doi: 10.3389/fendo.2025.1591390. eCollection 2025.
2
Nicotinamide N-Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets.烟酰胺N-甲基转移酶(NNMT)与肝癌:从代谢网络到治疗靶点
Biomolecules. 2025 May 14;15(5):719. doi: 10.3390/biom15050719.
3
DEP domain‑containing 1 is a prognostic biomarker associated with the cell cycle in gliomas.

本文引用的文献

1
KEGG: integrating viruses and cellular organisms.KEGG:整合病毒和细胞生物。
Nucleic Acids Res. 2021 Jan 8;49(D1):D545-D551. doi: 10.1093/nar/gkaa970.
2
A negative reciprocal regulatory axis between cyclin D1 and HNF4α modulates cell cycle progression and metabolism in the liver.细胞周期蛋白D1与肝细胞核因子4α之间的负向相互调节轴调控肝脏中的细胞周期进程与代谢。
Proc Natl Acad Sci U S A. 2020 Jul 21;117(29):17177-17186. doi: 10.1073/pnas.2002898117. Epub 2020 Jul 6.
3
Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2.
含DEP结构域蛋白1是一种与胶质瘤细胞周期相关的预后生物标志物。
Oncol Lett. 2025 Apr 7;29(6):276. doi: 10.3892/ol.2025.15022. eCollection 2025 Jun.
4
Progressive Deactivation of Hydroxylases Controls Hypoxia-Inducible Factor-1α-Coordinated Cellular Adaptation to Graded Hypoxia.羟化酶的渐进性失活控制缺氧诱导因子-1α协调的细胞对分级缺氧的适应性。
Research (Wash D C). 2025 Apr 1;8:0651. doi: 10.34133/research.0651. eCollection 2025.
5
Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications.肝细胞癌中的代谢重编程:机制与治疗意义
Exp Mol Med. 2025 Mar;57(3):515-523. doi: 10.1038/s12276-025-01415-2. Epub 2025 Mar 3.
6
Exploring Aerobic Energy Metabolism in Breast Cancer: A Mutational Profile of Glycolysis and Oxidative Phosphorylation.探索乳腺癌中的有氧能量代谢:糖酵解和氧化磷酸化的突变谱
Int J Mol Sci. 2024 Nov 23;25(23):12585. doi: 10.3390/ijms252312585.
7
Roles of DEPDC1 in various types of cancer (Review).DEPDC1在各类癌症中的作用(综述)
Oncol Lett. 2024 Aug 29;28(5):518. doi: 10.3892/ol.2024.14651. eCollection 2024 Nov.
8
DEPDC1 as a metabolic target regulates glycolysis in renal cell carcinoma through AKT/mTOR/HIF1α pathway.DEP 结构域蛋白 1 作为代谢靶点通过 AKT/mTOR/HIF1α 通路调节肾细胞癌中的糖酵解。
Cell Death Dis. 2024 Jul 27;15(7):533. doi: 10.1038/s41419-024-06913-1.
9
Targeting hexokinase 2 for oral cancer therapy: structure-based design and validation of lead compounds.靶向己糖激酶2用于口腔癌治疗:基于结构的先导化合物设计与验证
Front Pharmacol. 2024 Mar 11;15:1346270. doi: 10.3389/fphar.2024.1346270. eCollection 2024.
10
Cryptocaryone induces apoptosis in human hepatocellular carcinoma cells by inhibiting aerobic glycolysis through Akt and c-Src signaling pathways.隐丹参酮通过抑制 Akt 和 c-Src 信号通路抑制有氧糖酵解诱导人肝癌细胞凋亡。
J Food Drug Anal. 2023 Dec 15;31(4):696-710. doi: 10.38212/2224-6614.3480.
相互作用组分析显示,lncRNA HULC 通过 LDHA 和 PKM2 促进有氧糖酵解。
Nat Commun. 2020 Jun 22;11(1):3162. doi: 10.1038/s41467-020-16966-3.
4
HCG18/miR-34a-5p/HMMR axis accelerates the progression of lung adenocarcinoma.HCG18/miR-34a-5p/HMMR 轴促进肺腺癌的进展。
Biomed Pharmacother. 2020 Sep;129:110217. doi: 10.1016/j.biopha.2020.110217. Epub 2020 Jun 16.
5
A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylation.一种用于诊断、预后、治疗和肝癌化疗耐药的新策略:DNA 甲基化。
Med Res Rev. 2020 Sep;40(5):1973-2018. doi: 10.1002/med.21696. Epub 2020 Jun 11.
6
Activating miRNA-mRNA network in gemcitabine-resistant pancreatic cancer cell associates with alteration of memory CD4 T cells.吉西他滨耐药胰腺癌细胞中激活的miRNA-mRNA网络与记忆性CD4 T细胞的改变有关。
Ann Transl Med. 2020 Mar;8(6):279. doi: 10.21037/atm.2020.03.53.
7
Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide study.肝癌合并门静脉癌栓患者肝切除术后的真实长期生存:一项全国性研究。
Hepatol Int. 2020 Sep;14(5):754-764. doi: 10.1007/s12072-020-10032-2. Epub 2020 Apr 6.
8
B cells are associated with survival and immunotherapy response in sarcoma.B 细胞与肉瘤的生存和免疫治疗反应有关。
Nature. 2020 Jan;577(7791):556-560. doi: 10.1038/s41586-019-1906-8. Epub 2020 Jan 15.
9
B cells and tertiary lymphoid structures promote immunotherapy response.B 细胞和三级淋巴结构促进免疫治疗反应。
Nature. 2020 Jan;577(7791):549-555. doi: 10.1038/s41586-019-1922-8. Epub 2020 Jan 15.
10
FOXE1 represses cell proliferation and Warburg effect by inhibiting HK2 in colorectal cancer.FOXE1 通过抑制结直肠癌细胞中的 HK2 来抑制细胞增殖和瓦博格效应。
Cell Commun Signal. 2020 Jan 9;18(1):7. doi: 10.1186/s12964-019-0502-8.